Maintaining a Hold rating on Larimar Therapeutics due to early-stage development of nomlabofusp for Friedreich’s ataxia and uncertainty about its functional benefits. The stock has dropped over ...
BALA CYNWYD, Pa. (AP) — BALA CYNWYD, Pa. (AP) — Larimar Therapeutics, Inc. (LRMR) on Monday reported a loss of $28.8 million in its fourth quarter. The Bala Cynwyd, Pennsylvania-based company ...
The latest price target for Larimar Therapeutics (NASDAQ:LRMR) was reported by Guggenheim on March 25, 2025. The analyst firm set a price target for $26.00 expecting LRMR to rise to within 12 ...
The eerie triple-0 call Paul Thijssen made in the hours after he murdered Lilie James in a high school gymnasium bathroom has been released. The 24-year-old, who worked with Ms James, struck the ...
March 24, 2025 (GLOBE NEWSWIRE) -- Larimar Therapeutics, Inc. (Larimar) (Nasdaq: LRMR), a clinical-stage biotechnology company focused on developing treatments for complex rare diseases, today ...
Gladstone junior Lillie Johnson steps off the bus before a MHSAA Division 2 regional championship game against Fremont on March 9, 2025 at Houghton Lake High School. (“The Big Dog” Mitch Vosburg/Daily ...
Explore Larimar Therapeutics stock price, quotes, charts and forecasts with Benzinga. Stay updated on market trends for LRMR. Larimar Therapeutics reports promising FXN level increases with 25 mg ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback